ArticleOncoimmunology
Development of thyroid dysfunction is associated with clinical response to PD-1 blockade treatment in patients with advanced non-small cell lung cancer.
Hye In Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
69 papers cite itlatest 60 shown
pooled ittrialcites it